Cargando…
Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
BACKGROUND: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. OBJECTIVE: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth factor 23 (FGF-23) in hemodialysis (HD) patients and renal transplant recipie...
Autores principales: | Eskandari Naji, H., Ghorbanihaghjo, A., Argani, H., Raeisi, S., Safa, J., Alirezaei, A. H., Rashtchizadeh, N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549008/ https://www.ncbi.nlm.nih.gov/pubmed/28828171 |
Ejemplares similares
-
The Diagnostic Value of sTWEAK in Acute Ischemic Stroke
por: Comertpay, Ertan, et al.
Publicado: (2020) -
Effect of Nandrolone Decanoate on Serum Lipoprotein (a) and its isoforms in hemodialysis patients
por: Ghorbanihaghjo, Amir, et al.
Publicado: (2004) -
sTWEAK is a leukoaraiosis biomarker associated with neurovascular angiopathy
por: da Silva‐Candal, Andrés, et al.
Publicado: (2022) -
The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation
por: da Silva‐Candal, Andrés, et al.
Publicado: (2020) -
Effect of Isoproterenol on LDL Susceptibility to Oxidation and Serum Total Antioxidant Capacity in Cyclosporine-Treated Rats
por: Foroughimoghaddam, H., et al.
Publicado: (2010)